| 1. |
Okamoto I, Sato H, Kondo T, Fushimi C, Okada T, Miura K, Okumura G, Matsuki T, Yamashita T, Tsukahara K: Post-operative complications due to salvage total laryngectomy for recurrent laryngeal cancer after radiotherapy - a multicentre retrospective study. Acta Otolaryngol 140: 170-174, 2020 |
| 2. |
Okamoto I, Sato H, Tsukahara K: Overall survival and PD-L1 expression in patients with recurrent or metastatic head and neck cancer treated with nivolumab. Auris Nasus Larynx 47: 676-686, 2020 |
| 3. |
Sato H, Fushimi C, Okada T, Matsuki T, Kondo T, Omura G, Miura K, Yamashita T, Okamoto I, Tsukahara K: Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma. In Vivo 34: 2967-2972, 2020 |
| 4. |
Kondo T, Okamoto I, Sato H, Koyama N, Fushimi C, Okada T, Masubuchi T, Miura K, Matsuki T, Yamashita T, Omura G, Takahashi H, Tsukahara K: Age-based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study. Asia Pac J Clin Oncol 16: 340-347, 2020 |
| 5. |
Katsube Y, Okamoto I, Sato S, Kondo T, Okada T, Tsukahara K: Safety of S-1 as Adjuvant Chemotherapy after Curative Treatment in Head and Neck Cancer Patients who are >75 years old. Journal of Tokyo Medical University : 78: 307-311,2020 |
| 6. |
Ueda Y, Enokida T, Okano S, et al.: Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. Front Oncol.7 doi: 10.3389/fonc.2020.571304. eCollection 2020 |
| 7. |
Takeda A, Takano N, Kokuba H, Hino H, Moriya S, Abe A, Hiramoto M, Tsukahara K, Miyazawa K: Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization-associated cell death. International Journal of Oncology 57: 1280-1292, 2020 |
| 8. |
Maruyama R, Okamoto I, Sato H, Katube Y,Kondo T, Tsukahara K: Prediction of therapeutic effects from one course of TPF chemotherapy for advanced hypopharyngeal laryngeal cancer. In Vivo 34: 2891-2896, 2020 |
| 9. |
Miyake K, Shirai K, Nishiyama N, Kawaguchi S, Ohta Y, Kawano A, Usami S, Kitano T, Tsukahara K: Cochlear implantation in patient with a POU4F3 mutation. Clinical Case Reports 9: 298-303, 2020 |
| 10. |
Miyake K, Kondo T, Koyama N, Hirano H, Wakiya M, Takeda A, Iwasawa T, Kikawada N, Hanyu K, Ogawa Y, Tsukahara K: Simultaneous metastasized primary unknown signet ring cell carcinoma of the cervical lymph node and mucoepidermoid carcinoma of the parotid gland as double cancers. Auris Nasus Larynx 47: 163-167, 2020 |
| 11. |
Yamashita G, Kondo T, Okimura A, Nakatsugawa M, Hirano H, Takeda A, Kikawada N, Aihara: Occult Papillary Thyroid Carcinomawithout Detection of the Primary Tumoron Preoperative Ultrasonography orPostoperative Pathological Examination: Case Rep Oncol. 13:105-112, 2020. |
| 12. |
Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, et al.: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study. Int J Clin Oncol.doi: 10.1007/s10147-020-01829-0. |
| 13. |
Matsuki T, Okamoto I, Fushimi C, Takahashi H, Okada T, Kondo T, Sato H, Ito T, Tokashiki K, Tsukahara K, Hanyu K, et al.: Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients. Cancersdoi: 10.3390/cancers12113427. |
| 14. |
Shiga K, Nibu K, Fujimoto Y, Asakage T, Homma A, Mitani H, Ogawa T, Okami K, Murono S, Hirano S, Ueda T, Hanai N, Tsukahara K, et al.: Multi-institutional Survey of Squamous Cell Carcinoma of the External Auditory Canal in Japan. Laryngoscope doi: 10.1002/lary.28936. |
| 15. |
Yamaguchi H, Sato H, Tsukahara K, Kagawa Y, Okamoto I, Shimizu A, et al.: Co-treatment with endoscopic laryngopharyngeal surgery and endoscopic submucosal dissection. Auris Nasus Larynx doi: 10.1016/j.anl.2020.10.003. |
| 16. |
Niwa K, Saotome T, Okazaki M, Yamazaki K, Okamoto I, Hirai H, Saigusa N, Fushimi C, Masubuchi T, Miura K, Okazaki SI, Matsui H, Okada T, Iwaki S, Matsuki T, Hanyu K, Tsukahara K, et al.: Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma. Sci Rep. doi: 10.1038/s41598-020-73965-6. |
| 17. |
Fushimi C, Okamoto I, Matsuki T, Masubuchi T, Okada T, Sato H, Tsukahara K, Kondo T, et al.: Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma. Anticancer Res. doi: 10.21873/anticanres.14532. |
| 18. |
Okumura Y, Nakano S, Murase T, Ueda K, Kawakita D, Nagao T, Kusafuka K, Urano M, Yamamoto H, Kano S, Tsukahara K, et al.: Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study. Cancer Sci.doi: 10.1111/cas.14632. |
| 19. |
Ichimasu N, Kohno M, Nakajima N, Matsushima K, Tanaka Y, Tsukahara K, Inagaki T, et al.: Long-term prognosis of preserved useful hearing after surgery in patients with vestibular schwannoma: a study of 91 cases. Acta Neurochirurgia 162: 2619-2628, 2020 |
| 20. |
Kawakita D, Okamoto I, Fushimi C, Sawabe M, Kawakita D, Sato H, Tsukahara K, Kondo T, Okada T, et al.: The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan. Int J Clin Oncol.doi: 10.1007/s10147-020-01731-9. |
| 21. |
Matsuki T, Okamoto I, Fushimi C, Sawabe M, Kawakita D, Sato H, Tsukahara K, Kondo T, Okada T, et al.: Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients. Cancer Med. doi: 10.1002/cam4.3124. |
| 22. |
Hirai H, Tada Y, Nakaguro M, Kawakita D, Sato Y, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Okamoto I, Takase S, Okada T, Sato H,: The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma. Virchows Arch. 477: 291-299, 2020 |
| 23. |
Ueda K, Murase T, Nagao T, Kusafuka K, Urano M, Yamamoto H, Nakaguro M, Taguchi KI, Masaki A, Hirai H, Kawakita D, Tsukahara K, et al.: Central pathology review of salivary gland adenoid cystic carcinoma. Head Neck 42: 1721-1727, 2020 |
| 24. |
Nakaguro M, Sato Y, Tada Y, Kawakita D, Hirai H, Urano M, Shimura T, Tsukahara K, et al.: Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model. Am J Surg Pathol. 44: 526-535, 2020 |
| 25. |
Araki K, Tomifuji M, Shiotani A, Hirano S, Yokoyama J, Tsukahara K, et al.: Minimally invasive surgery for laryngopharyngeal cancer: Multicenter feasibility study of a combination strategy involving transoral surgery and real-time indocyanine green fluorescence-navigated sentinel node navigation surgery. Head Neck 42: 254-261, 2020 |
| 26. |
Nomura Y, Toi T, Ogawa Y, Ohshima T, Saito Y: Transitional nystagmus in a Bow Hunter's Syndrome case report. BMC Neurology 20: 435, 2020 |
| 27. |
Matsuki T, Okamoto I, Tada Y, et al.: Resection of Parapharyngeal Space Tumors Located in the Prestyloid Compartment: Efficacy of the Cervical Approach. Ann Surg Oncol. doi: 10.1245/s10434-020-09268-x. |
| 28. |
Fukunaga I, Shirai K, Kawano A, Kamiya K, et al.: Generation of two induced pluripotent stem cell lines from PBMCs of siblings carrying c.235delC mutation in the GJB2 gene associated with sensorineural hearing loss. Stem Cell Res. : doi.org/10.1016/j.scr.2020.101910 |
| 29. |
Ishikawa Y, Suzuki M, Yanagi Y, Kurihara M, Kawamura N,Konomi U.: Efficacy of Nasal Airflow-Inducing Maneuver in Laryngectomy Patients: A Retrospective Cohort Study. Laryngoscope 130: 2013-2018, 2020 |
| 30. |
Okui A, Konomi U, Watanabe Y.: Complaints and Complications of Microlaryngoscopic Surgery. J Voice. 34: 949-955, 2020 |
| 31. |
Okui A, Konomi U, Kanazawa T, et al. Therapeutic Efficacy of Basic Fibroblast Growth Factor in Patients With Vocal Fold Atrophy. Laryngoscope 130: 2847-2852, 2020 |
| 32. |
Sakaguchi Y, Kanazawa T, Okui A, Hirosaki M, Konomi U, et al. Assessment of Dysphonia Using the Japanese Version of the Voice Handicap Index and Determination of Cutoff Points for Screening. J Voice. doi:10.1016/j.voice.2020.04.031. |
| 33. |
Ymaguchi H, Fukuzawa M, Kawai T, Sato H, Itoi T: Successful resection of a giant pedunculated pharyngeal liposarcoma by endoscopic submucosal dissection with countertraction using grasping forceps. VideoGIE 5: 643-645, 2020 |
| 34. |
塚原清彰：PD-1阻害剤(頭頸部癌). 日本気管食道科学会会報 71: 338-340, 2020 |
| 35. |
塚原清彰：気管切開に関する死亡事故回避～事故調・提言書分析部会員を経験して. 日本気管食道科学会会報 71: 80-81, 2020 |
| 36. |
塚原清彰：da Vinci手術支援ロボットによる経口腔支援手術transoral robotic surgery(TORS). ENTONI 247: 51-57, 2020 |
| 37. |
塚原清彰：深頸部膿瘍. 日本医事新報 4999: 48, 2020 |
| 38. |
小川恭生：「めまい平衡検査の原点から現状、そして未来へ」自覚的視性垂直位. Equiribrium Research 79: 211-217, 2020 |
| 39. |
小川恭生：「早わかり診療ガイドライン100-エッセンス&リアルワールド」耳鼻咽喉科 末梢性めまい・良性発作性頭位めまい症 良性発作性頭位めまい症診療ガイドライン(医師用) . Medicina 57: 394-399, 2020 |
| 40. |
西山信宏：「補聴器と人工感覚器の最前線2020」補聴器と人工聴覚器の両耳聴効果. 耳鼻咽喉科・頭頸部外科 92: 48-51, 2020 |
| 41. |
清水 顕，塚原清彰：頭頸部領域のロボット手術を始める 頭頸部ロボット支援手術に関する教育プログラム -実施結果の検証-. 頭頸部外科 30: 133-137, 2020 |
| 42. |
清水 顕：Up-to-date ロボット支援手術. 喉頭 32: 147-150, 2020 |
| 43. |
清水 顕：特集 AIとロボット手術本邦における手術支援ロボットロボット手術の現状と今後の方向性. JOHNS 36: 1629-32, 2020 |
| 44. |
清水 顕：質疑応答 プロからプロへ 耳鼻咽喉科 頭頸部癌の経口的ロボット支援手術について. 日本医事新報 4996: 54, 2020 |
| 45. |
岡本伊作，塚原清彰：【がん免疫療法の最前線】がん免疫療法とバイオマーカー(解説/特集). JOHNS 6: 428-430, 2020 |
| 46. |
岡本伊作，塚原清彰：【頭頸部癌免疫療法の最前線】頭頸部癌免疫療法の実際 症例から学ぶ(2)(解説/特集). ENTONI 246: 41-46, 2020 |
| 47. |
太田陽子：学会賞：成人人工内耳蝸牛内骨化 9 例の聴取能評価. 耳鼻臨床 112: 219-223, 2019 |
| 48. |
上田百合，榎田智弘，田原 信：【頭頸部癌免疫療法の最前線】頭頸部癌の免疫療法の開発. ENTONI 246: 9-18, 2020 |
| 49. |
武田淳雄：耳鼻咽喉科の世界-第1章- 構造と機能. 東京都薬剤師会 都薬雑誌 42: 4-9, 2020 |
| 50. |
武田淳雄：耳鼻咽喉科の世界-第2章- 耳疾患について. 東京都薬剤師会 都薬雑誌 42: 6-11, 2020 |
| 51. |
武田淳雄：耳鼻咽喉科の世界-第3章- 鼻疾患について. 東京都薬剤師会 都薬雑誌 42: 9-14, 2020 |
| 52. |
武田淳雄：耳鼻咽喉科の世界-第4章- ノド疾患について. 東京都薬剤師会 都薬雑誌 42: 4-8, 2020 |
| 53. |
岸田拓磨，佐藤宏樹，丸山 諒，清水 顕，勝部泰彰，冨岡亮太，田中英基，塚原清彰：導入化学療法とセツキシマブ併用放射線療法を施行したHIV陽性者の中咽頭癌例. 耳鼻咽喉科臨床 113: 111-116, 2020 |
| 54. |
千葉裕人，小川恭生：CASE-5 第Ⅷ脳神経神経血管圧迫症候群によるめまい. EQUILIBRIUM RESEARCH 79: 290-292, 2020 |
| 55. |
藤井翔太，井谷茂人，稲垣太郎，塚原清彰：舌骨に癒合した巨大な茎状突起過長症例. 耳鼻咽喉科臨床 113: 241-244, 2020 |
| 56. |
伊藤達哉，岡本伊作，塚原清彰，佐藤宏樹，岡田拓朗：上顎洞に発生したspindle cell sarcomaを手術治療した1例. 耳鼻咽喉科・頭頸部外科 92: 943-947, 2020 |
| 57. |
吉田重和，佐藤宏樹，岡本伊作，勝部泰彰，冨岡亮太，清水 顕，塚原清彰：外切開・下咽頭部分切除術に内視鏡手術を併用した下咽頭癌の1例. 耳鼻咽喉科・頭頸部外科 92: 937-942, 2020 |
| 58. |
田中悠二郎，橋本孝朗，横山智哉，新井佑輔，菊野宗明，佐藤宏樹，塚原清彰，河野道宏：Carotid blowout syndromeに対しcover stentで治療するも再出血した１例. 脳神経外科 48: 935-940, 2020 |
| 59. |
北島尚治，北島明美，北島清治：開放耳管を伴うスクーバダイバー患者の検. 日本耳鼻咽喉科学会会報 123: 55-62, 2020 |
| 60. |
北島尚治：スポーツ医学と耳鼻咽喉科【スポーツと耳鼻咽喉科疾患】ダイビングと耳鼻咽喉科. JOHNS 36: 591-595, 2020 |
| 61. |
北島尚治：耳鼻咽喉科診療Q&A 9．飛行機やダイビングで耳抜きができない人に対する上手な指導法や対応はありますか. JOHNS 36: 1074-1075, 2020 |
| 62. |
北島尚治：耳鼻咽喉科医に必要なスポーツ診療の知識 スクーバダイビング. ENTONI 243: 52-61, 2020 |
| 63. |
青木光広，城倉 健, 土井勝美，田浦晶子，結縁晃治，稲垣太郎，角南貴司子，許斐氏元：めまい相談医制度に関するアンケート調査. Equilibrium Research 79: 202-204, 2020 |
